Tag

Tagged: leadership

Sponsored
  • MedTech companies must shift from incremental improvements to transformative innovation to stay competitive in a fast-paced healthcare landscape
  • Exploring adjacent markets, such as personalised medicine and digital health, is crucial for growth in slow-moving markets
  • Embedding user experience research into product development helps address real-world healthcare needs and fosters faster market adoption
  • Embracing data-driven healthcare and digital solutions is essential for staying relevant and creating new revenue streams

Revitalising MedTech Innovation: Strategies for Growth

The MedTech industry has been a powerhouse of healthcare innovation, responsible for ground-breaking medical devices and diagnostics that save lives. However, many traditional MedTech companies now grapple with stagnant growth, low valuations, and a widening gap between the industry's trailblazers and those struggling to keep pace. While emerging firms leverage agile, tech-driven strategies, many established players remain anchored to legacy products, incremental research and development (R&D), and risk-averse leadership, making it difficult to adapt in a fast-evolving market. To regain momentum and drive sustainable growth, MedTech companies must shift from reactive management to a proactive, innovation-centric approach. This entails leveraging emerging technologies, fostering a culture of decisive action, and refocusing R&D efforts to address critical unmet healthcare needs. By adopting these forward-looking strategies, underperforming MedTechs can reclaim their roles as leading innovators in healthcare, delivering solutions and services that meet modern demands and improve patient outcomes.
 
In this Commentary

This Commentary explores actionable strategies for futureproofing MedTech businesses. By embracing breakthrough innovations, expanding, and diversifying product portfolios, and fostering a customer-centric culture, MedTech leaders can proactively address market shifts. Additionally, embedding digital transformation throughout operational processes is essential for creating agile, responsive, and efficient organisations. Together, these approaches enable executives to drive meaningful, lasting change and unlock pathways to sustainable growth, positioning MedTech firms to thrive amid evolving industry challenges and demands.
 
Shift from Incrementalism to Breakthrough Innovation
Challenge Many MedTech firms focus on incremental improvements rather than bold innovation, limiting their ability to capture new markets and drive value.
Strategy Establish a dual R&D structure that separates incremental improvements from high-impact, breakthrough innovation. Dedicate resources to a “safe zone” for bold projects, free from immediate commercial pressures. Setting up in-house innovation hubs, acquiring start-ups, and partnering with research institutions can spur innovation.
Example Medtronic’s integration of AI and deep learning in diabetes and cardiac care is an example of transformational R&D.


Recalibrate the Portfolio: Diversify Beyond Core Offerings
Challenge Over-reliance on legacy products ties firms to slow-growth markets, hindering revenue diversification.
Strategy Conduct a thorough portfolio review to identify areas ripe for growth, such as personalised medicine, digital health, and regenerative medicine. Shifting focus to high-growth areas like genomics and biomaterials offers opportunities to unlock new revenue streams. By targeting adjacent markets or entering non-traditional spaces, companies can reposition themselves in emerging sectors.
Example Companies investing in personalised healthcare could use DNA profiling to tailor interventions, opening lucrative new markets. Collaborations with biotech firms in genome editing or regenerative technologies could also catalyse future growth.


Adopt a Customer-Centric Innovation Approach
Challenge MedTech development has traditionally been product-centric, often failing to meet the nuanced needs of healthcare providers and patients.
Strategy Embed user experience (UX) research and human-centred design principles into product development to ensure products are patient- and clinician-friendly. This approach increases adoption rates, as products designed with customer insights tend to address pain points.
Example Boston Scientific exemplifies this shift by applying UX design to enhance patient comfort and clinician ease of use. Transitioning to customer-centric models can help companies pivot from product-driven to problem-solving approaches.


Embrace Digital Transformation and Data-Driven Healthcare
Challenge Many MedTech firms lag in adopting digital technologies, risking challenges as healthcare digitalises.
Strategy Develop a digital-first mindset across the organisation. This transformation is essential as leaders often lack digital experience, posing a barrier. Leverage insights from digital natives and integrate digital health solutions like AI, Internet of Things (IoT), and data analytics to deliver value beyond single-device sales. Creating data-driven insights can open service-oriented revenue streams and deepen relationships with healthcare providers.
Example Zimmer Biomet’s ZBEdge suite combines devices, robotics, and digital tools to offer a comprehensive solution in orthopaedics, exemplifying how digital integration can redefine care models and revenue approaches.


Shift to Disciplined Strategic M&A
Challenge MedTech companies have leaned heavily on M&A for growth, but this has often led to inefficiencies and diluted focus. Poor integration and cultural misalignment have created silos, compliance risks, and stifled innovation.
Strategy Adopt disciplined M&A targeting long-term goals, such as filling product pipeline gaps or entering high-growth markets. Plan integrations with clear success metrics and cultural alignment, while focusing on acquisitions that enhance core strengths and agility. Investments in digital health, AI-driven diagnostics, and precision medicine can drive sustainable growth.
Example Stryker’s acquisition of MAKO Surgical exemplifies strategic M&A. By integrating robotics into its orthopaedics portfolio, Stryker enhanced innovation and reshaped its market positioning, demonstrating the transformative potential of a well-planned acquisition.


Foster a Culture of Innovation and Risk-Taking
Challenge Traditional MedTech cultures are often bureaucratic and risk-averse, stifling creativity and limiting innovation potential.
Strategy Transform company culture to encourage cross-functional collaboration, calculated risk-taking, and intraprenerial thinking. Leaders should eliminate bureaucratic hurdles, reward risk-takers, and foster a collaborative environment. Initiatives like internal pitch days or innovation hubs can stimulate new ideas.
Example Johnson & Johnson’s JLABS, a network of incubators, provides start-ups with mentorship and resources, fostering a culture of innovation that could be mirrored in larger organisations to inspire bold thinking.


Invest in Partnerships and Ecosystems
Challenge Innovation in MedTech often requires expertise beyond in-house capabilities, and few companies maximise external collaborations.
Strategy Develop global partnerships that provide access to cutting-edge research, new technologies, and emerging markets. Collaborations with academic institutions, start-ups, and tech companies can bridge skills gaps and facilitate access to advanced tools and knowledge.
Example Philips’ partnership with Salesforce enhances data integration for improved patient management, while GE HealthCare's collaboration with Microsoft advances AI in diagnostics, illustrating how alliances with tech firms can enhance digital capabilities and drive innovation.


Explore New Business Models Aligned with Value-Based Healthcare
Challenge As healthcare shifts to outcomes-based models, traditional device sales may no longer suffice.
Strategy Shift from a product-centric to a service-oriented model, considering subscription-based or “pay-per-outcome” approaches. Providing a device as part of a package with data analytics, predictive maintenance, or AI insights can create ongoing revenue streams and align with healthcare’s emphasis on outcomes.
Example Zimmer Biomet’s ZBEdge is not only a device but a comprehensive solution, offering surgeons real-time feedback and analytics, showcasing a shift from device sales to value-oriented services.


Overcome Regulatory Challenges Through Innovation
Challenge MedTech’s complex regulatory landscape can stifle bold innovation if firms focus only on incremental updates.
Strategy Forge early partnerships with regulatory bodies, aligning product development with regulatory goals for smoother approvals. Engaging with regulators early can also shape policies on emerging technologies, helping firms navigate new frameworks for AI, digital diagnostics, and bioengineering.
Example Illumina’s proactive engagement with regulators positioned the company as a leader in genomics by helping to shape regulatory standards, setting the stage for industry-wide acceptance of its cutting-edge tools.


Empower the Next Generation of Leaders
Challenge Today’s senior leadership often consists of experienced executives in their mid-50s who may not have fully embraced digital transformation. Many are digital migrants (people raised before the digital age), more comfortable with established processes and legacy offerings than the emerging tech-driven landscape. As they approach the final years of their careers, there is a natural tendency to focus on maintaining the status quo rather than pivoting to disruptive innovations.
Strategy To secure a sustainable future, it is essential to actively build a leadership pipeline that values digital acumen, agility, and forward-looking expertise. Begin by identifying and promoting emerging leaders who excel in these areas, fostering a culture that prioritises continuous learning, adaptability, and digital fluency. Creating a structured, ongoing knowledge-sharing platform will encourage seasoned executives to mentor younger leaders, while simultaneously opening avenues for them to learn from digitally fluent peers. Additionally, drive data-driven decision-making across all levels of leadership, ensuring that strategies reflect the fast-paced evolution of MedTech and adjacent industries.
Actionable Steps
  • Promote Cross-Generational Learning Pair senior leaders with high-potential younger talent in mentorship programmes that encourage reciprocal knowledge exchange.
  • Implement Digital Skills Development Programmes Provide tailored training for senior executives to boost comfort and proficiency with digital tools and data analytics, positioning them to lead more confidently in a tech-forward environment.
  • Build Agility into Decision-Making Processes Shift from rigid hierarchies to a more flexible, data-driven approach. Encourage leaders to adopt an iterative, evidence-based style that aligns with rapid industry changes.
  • Invest in Leadership with Expertise in Emerging Fields Actively recruit and cultivate future leaders skilled in biotech, digital health, and AI to ensure readiness for MedTech’s inevitable transformation.
Example By strategically investing in future leaders with strengths in digital health and biotech, companies can secure a foothold in next-generation markets. Not only will this keep organisations ahead of industry trends, but it will also empower them to lead MedTech’s transformation, ensuring long-term viability and growth.
 
Takeaways

To effectively revitalise traditional MedTech companies, leaders must embrace a transformative, growth-oriented approach that departs from conventional practices. This transformation requires prioritising breakthrough innovations, expanding product portfolios, and establishing a customer-centric mindset. Digital transformation must be at the core, enabling greater efficiency and faster responses to market demands. Additionally, effective knowledge management and a culture of continuous improvement are essential to harness and optimise strategic assets, ensuring that valuable insights and expertise are not lost but actively leveraged for competitive advantage.

The goal is not just to keep pace with the industry but to redifine its trajectory and lead the way in  shaping the future of healthcare. By proactively implementing the recommended strategies, MedTech firms can secure a stronger financial foundation, drive meaningful advancements in patient care, and maintain a competitive edge in an ever-evolving landscape. Bold decisive action is critical, as it lays the groundwork for enduring success, resilience, and recognition as an industry leader. By following the outlined roadmap, companies can position themselves as key contributors to the healthcare sector’s transformation, ensuring improved patient outcomes and reinforcing their relevance in a rapidly changing world.
view in full page
  • Today’s workforce and consumers expect corporations to stay responsive and forward-thinking, echoing voter sentiment in the 2024 US Presidential Election
  • The Election outcome highlights the risks for healthcare and MedTech firms that remain attached to outdated practices in fast-changing markets
  • Traditional executives may lack the digital fluency needed to keep pace with technological and market advancements
  • By embracing varied perspectives and future-oriented strategies, corporations can better align with evolving employee and customer expectations
 
A Wake-Up Call for US Corporations in Fast-Changing Industries

Donald Trump's victory in the November 2024 US Presidential Election suggests lessons - not only for the political sphere but also for corporate leaders, particularly in fast-changing sectors like healthcare and MedTech. While a range of factors contributed to the former president's decisive win, this Commentary focuses on a few themes that stand out for their relevance to business: the weight of legacy issues, the disconnect between leaders and their broader constituencies, and the perils of overconfidence and resistance to change. By addressing core concerns like inflation, economic security, and future opportunities, Trump’s platform resonated with voter priorities, highlighting a gap between traditional leaders and the public. This shift underscores the risks faced by established institutions, both political and corporate, when they fail to respond to legitimate concerns and adapt to dynamic environments.

Much like the political elites, corporate leadership in healthcare and MedTech - especially within conservative firms - risks being disconnected from the shifts of their industry and workforce. In these sectors, rapid innovation and changing market demands are reshaping the landscape. Yet a significant proportion of large companies remain anchored to legacy products and structures, headed by leadership teams largely comprised of US-based senior executives many of whom are nearing retirement. These digital migrants, whose careers were well established before digitalisation, may lack fluency in the latest technological advancements and market shifts, risking a strategic blind spot that leaves them vulnerable to more agile and innovative competitors. Drawing a parallel between the political and corporate worlds, it seems reasonable to suggest that ignoring changing demographics, employee needs, and technological trends introduces risks for corporations just as it does for political entities.

 
In this Commentary

This Commentary highlights how Donald Trump's 2024 Presidential election win serves as a cautionary tale for corporate leaders, especially in fast-evolving sectors like healthcare and MedTech. By drawing parallels between political and corporate spheres, it emphasises the risks for established firms that are slow to adapt to rapid changes in technology, market demands, regulations, and workforce expectations. Through analysis of healthcare trends and leadership dynamics, it provides insights on fostering adaptability, inclusivity, and a forward-thinking culture to stay competitive.
 
Legacy Leadership and the Risks of Inertia in a Fast-Paced Industry

Healthcare and MedTech, more so than many other sectors, are undergoing rapid and transformative changes driven by advancements in biomedical science, artificial intelligence (AI), value-based healthcare, and shifts in care delivery models. New technologies such as AI, machine learning, telehealth, and remote monitoring are driving innovation, as are changing consumer preferences and a growing emphasis on preventive care and patient-centred models. For traditional firms, adapting to these trends is challenging, and demands a readiness to embrace both internal and external changes swiftly and effectively.

Many large MedTech corporations are led by well-established leadership teams composed primarily of American males many of whom have established careers in a more predictable, slower-paced environment. These leaders, often digital immigrants, may lack the skills and cultural agility needed to navigate today’s digital-first landscape. In an industry where start-ups and smaller, more agile companies are increasingly setting the pace, being overly reliant on legacy products and markets and slow to innovate can create significant vulnerabilities.

Just as US voters in November 2024 demonstrated a desire for change by voting for populist policies, there is a growing segment within healthcare and MedTech firms - ranging from early-career employees to mid-level managers - who may feel left behind by leadership that appears out of touch. Such employees may feel that their aspirations, frustrations, and innovative ideas are overlooked, resulting in disillusionment that ultimately stifles creativity and limits the company’s ability to innovate.
 
Misalignment with Market Realities and Employee Expectations

Much like the dissonance between voter priorities and political platforms that played a role in the 2024 American Presidential election, traditional healthcare leaders face the risk of alienating their workforce by not aligning with their evolving expectations. Today’s employees seek flexibility, inclusivity, and growth opportunities, yet many corporate hierarchies remain anchored to legacy mindsets, appearing resistant to the innovation employees value. Amidst inflation, economic pressures, and a rapidly changing healthcare landscape, there is an expectation for companies to prioritise meaningful, sustainable changes over unwavering adherence to past practices.

Such a disconnect can lead to disengagement among skilled and innovative team members who feel side-lined in decision-making processes. In an era where top talent is essential to maintain competitive advantage, traditional corporations must cultivate an inclusive, agile, and future-oriented culture. Failing to address these demands risks losing valuable talent and diminishing the company’s ability to remain competitive.

 
Strategic Blind Spots: The Cost of Ignoring Innovation

Another parallel between the political and corporate spheres lies in the risk of overconfidence in legacy strategies. Just as political analysts underestimated the former President's appeal by relying on inadequate polling methodologies, traditional healthcare companies often misjudge market shifts by relying on legacy product lines and ignoring emerging trends. Such overconfidence in established offerings and processes can be costly in healthcare, where technology-driven innovation has opened new avenues for preventive care, personalised medicine, and outpatient services.

Firms that fail to recognise these shifts risk being blindsided by competitors who are more attuned to the demands of modern consumers. Smaller, more innovative firms are seizing opportunities in areas such as digital health, telemedicine, and wearable technology - offering patients and providers new ways to manage health conditions. These firms are not bound by legacy structures or outdated decision-making processes, allowing them to respond quickly to emerging trends and customer needs.

The trend toward outpatient services and home healthcare is especially significant. As healthcare delivery moves increasingly out of hospitals and into homes and community centres, traditional healthcare companies must rethink their approach to service delivery. A company that remains fixated on hospital-based care or physical products while ignoring digital health services or home-based solutions risks missing the next wave of healthcare innovation.

 
Embracing Change to Bridge the Divide

Trump’s 2024 victory draws attention to the risks of remaining wedded to the past. In his campaign, he demonstrated an ability to connect with voters by focusing on practical solutions to their everyday concerns. Healthcare corporations should consider adopting a similar approach by investing in solutions and services that address the needs of patients and employees. This could involve not only expanding product lines to include digital health tools and preventive care but also restructuring the organisation to make it more agile and responsive.

For corporate leaders, the takeaway is clear: organisations must prioritise responsiveness and agility over rigid adherence to traditional methods. Just as Trump’s victory revealed the risks of political elites being out of touch with public sentiment, corporate leaders risk alienating their workforce and missing growth opportunities by ignoring employee concerns and market trends.

 
Building a Culture of Inclusivity and Innovation
 
In a dynamic healthcare and MedTech landscape, companies need more than just technical expertise and financial acumen to stay competitive; they must foster a culture that values inclusivity, adaptability, and continuous learning. Just as well funded political institutions can lose touch with the needs and concerns of their constituents, corporate leaders risk disconnecting from the aspirations and behaviours of their employees and patients. By aligning more closely with different voices across the organisation - particularly younger, diverse employees and those with digital expertise - companies can tap into a broader spectrum of ideas, unlocking innovation that reinforces their market position.

To achieve this alignment, leaders should actively seek input from employees at all levels, appreciating that crucial insights often emerge from minority voices. This inclusive strategy not only drives engagement and fosters a culture of innovation but also positions the organisation to respond more effectively to both employee and patient needs.
 
The Path Forward: Adaptation as a Core Strategy

The lessons from the American 2024 Election suggest that political and corporate leaders alike must adapt to rapidly changing demographics and expectations. For healthcare and MedTech firms, this means developing strategies that are not only grounded in today’s market realities but also flexible enough to evolve as those realities change.

Adaptation in the healthcare sector could involve investment in new technologies, partnerships with innovative start-ups, and a willingness to experiment with new business models. Companies that can pivot to meet new demands - whether through expanding digital health capabilities, embracing remote monitoring, or exploring personalised medicine - will be better positioned to succeed in a rapidly changing market.

 
Takeaways

The 2024 US Presidential Election results suggest a lesson for corporate leaders: in a fast-paced world, adaptability and responsiveness are key to staying relevant. Just as political leaders risk losing public trust by holding onto past ideas, corporations that resist change undermine their competitive edge and risk alienating both employees and customers. For healthcare and MedTech companies especially, the path forward requires a commitment to innovation, inclusivity, and real-world impact, ensuring resilience in an era defined by continuous transformation.

The stakes are clear: just as political leaders risk losing public confidence by holding onto outdated platforms, companies that cling to legacy practices risk losing valuable talent and market share. Ultimately, the parallel between politics and business underlines a truth: in a world of change, the only sustainable strategy is a commitment to evolution.
view in full page